Detalles de la búsqueda
1.
Certolizumab pegol for the treatment of chronic plaque psoriasis: Results through 48 weeks from 2 phase 3, multicenter, randomized, double-blinded, placebo-controlled studies (CIMPASI-1 and CIMPASI-2).
J Am Acad Dermatol
; 79(2): 302-314.e6, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-29660421
2.
Safety of Long-term Treatment With Certolizumab Pegol in Patients With Crohn's Disease, Based on a Pooled Analysis of Data From Clinical Trials.
Clin Gastroenterol Hepatol
; 14(12): 1753-1762, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27464588
3.
Tuberculosis and viral hepatitis in patients treated with certolizumab pegol in Asia-Pacific countries and worldwide: real-world and clinical trial data.
Clin Rheumatol
; 40(3): 867-875, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32740672
4.
Correction to: Tuberculosis and viral hepatitis in patients treated with certolizumab pegol in Asia-Pacific countries and worldwide: real-world and clinical trial data.
Clin Rheumatol
; 39(10): 3161, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32876785
5.
Rapid onset of efficacy predicts response to therapy with certolizumab plus methotrexate in patients with active rheumatoid arthritis.
Korean J Intern Med
; 33(6): 1224-1233, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-29294598
6.
Certolizumab pegol plus methotrexate 5-year results from the rheumatoid arthritis prevention of structural damage (RAPID) 2 randomized controlled trial and long-term extension in rheumatoid arthritis patients.
Arthritis Res Ther
; 17: 245, 2015 Sep 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-26353833
Resultados
1 -
6
de 6
1
Próxima >
>>